COMMON SENSE INSTITUTE

Senseonics, a maker of implantable glucose monitors, has set the price for its upcoming stock sale. The company will offer eight million shares at five dollars each, aiming to bring in about eighty million dollars before fees. Investors can also receive pre‑funded warrants, which let them buy the sa

Common Cause Rhode Island has filed a complaint against Michael Magee, the former CEO of Chiefs for Change. The complaint alleges that Magee failed to register as a lobbyist, even though he was involved in steering a multimillion-dollar state education contract to the ILO Group. This came after Gove